Therapeutic patient education for adults with obesity and metabolic disorders
Official title: OBEDIAM: a Pilot Study of Therapeutic Patient Education in Adults Living With Obesity, Diabetes, and Metabolic Disorders
Run by CHU de Quebec-Universite Laval · NCT07668661 · Data updated 2026-11-12
Aimed at adults with obesity, this study tests whether a co-developed therapeutic patient education program is acceptable and feasible to help with daily self-management.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 42 (estimated) |
| Sponsor | CHU de Quebec-Universite Laval Academic / other |
| Locations | 1 site (Québec, Quebec) |
| Status | Recruiting |
| Started | October 30, 2026 |
| Main results expected | October 2027 |
| Study ends | December 2027 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT07668661 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 to 80 with BMI ≥30 kg/m2 and at least one obesity-related comorbidity, able to speak French and access the Internet, and willing to participate in questionnaires and focus groups.
✕Probably not a fit
Individuals with language barriers beyond French, lack of Internet access, or inability to consent may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study will develop a therapeutic patient education program for people living with obesity in the Quebec context. It will involve co-design with citizens and healthcare professionals, followed by assessment of acceptability and feasibility through questionnaires and focus groups up to nine months after the intervention. Participants are adults with BMI ≥30 kg/m2 and at least one obesity-related comorbidity, who speak French and have Internet access. The study emphasizes a person-centered approach to support self-management beyond weight loss. Outcomes focus on accessibility, engagement, and practical feasibility rather than clinical efficacy.
Why it matters
Potential benefit: If successful, the program could become a feasible, patient-centered resource to improve self-management and quality of life for people living with obesity.
How similar studies have gone: Previous work suggests therapeutic patient education can support self-management in obesity, but this specific co-developed, acceptability-focused approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18 to 80 * living with obesity defined by a BMI ≥ 30 kg/m2 with a stage ≥ 2 according to the Edmonton Obesity Staging System (EOSS) * and at least one obesity-related comorbidity, including type 2 diabetes, steatohepatitis associated with metabolic dysfunction (MASH), polycystic ovary syndrome or osteoarthritis * speaking and understanding French * having access to the Internet Exclusion Criteria: * inability to provide informed consent or to respond to questionnaires.
Where it's running
-
CHU de Quebec-Universite Laval
Québec, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Laetitia Michou, MD PhD — CHU de Quebec-Universite Laval
- Study coordinator: Laetitia Michou, MD PhD
- Email: laetitia.michou@crchudequebec.ulaval.ca
- Phone: +14185254444
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Frontal EEG Changes During Anesthesia in People With Obesity vs. Normal Weight
This study tests whether frontal brain activity patterns during anesthesia differ between adults with obesity and those of normal weight.
-
Resistance training to protect muscle during tirzepatide treatment
This study tests whether adding resistance training helps preserve thigh muscle mass in adults with obesity who are taking tirzepatide.
-
Inositol and Metformin with Mediterranean or Low-Carb Diets in Women with PCOS
This trial tests whether adding inositol, metformin, or folic acid to either a Mediterranean or a low-carbohydrate diet helps women with PCOS and insulin resistance lose weight and improve metabolic markers.
-
Fasting for 84 Hours: How It Affects Fat Burning and Muscle Basics in Young Adults
This study tests whether 84 hours of fasting changes peak fat oxidation, how efficiently mitochondria couple their energy, and the extracellular matrix in four groups of young people who are normal weight or obese.
-
Replacing refined-carb foods with avocado to test inflammation markers
This study tests whether swapping foods high in refined carbs with avocado (while keeping calories the same) lowers inflammation and improves insulin sensitivity in adults with elevated hs-CRP and central obesity.
-
Circadian Gene Changes in People with Glucocorticoid Disorders
This study tests whether circadian gene expression in blood cells differs between people with glucocorticoid disorders and healthy controls.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.